<p id="thickbox_headline">The European Union's drug regulator on Tuesday expressed doubts about the need for a fourth booster dose of Covid-19 vaccine and said there is currently no data to support this approach as it seeks more data on the fast-spreading Omicron variant.</p>.<p>"While use of additional boosters can be part of contingency plans, repeated vaccinations within short intervals would not represent a sustainable long-term strategy," the European Medicines Agency's Head of Vaccines Strategy, Marco Cavaleri, told a media briefing.</p>.<p>The EMA official raised concerns that a strategy of giving boosters every four months hypothetically poses the risk of overloading people's immune systems and leading to fatigue in the population.</p>.<p>Cavaleri also said more data on the impact of the new variant on vaccines and a better understanding of the evolution of the current wave were needed to decide whether an Omicron-specific vaccine was needed.</p>.<p>"It is important that there is a good discussion around the choice of the composition of the vaccine to make sure that we have a strategy that is not just reactive ... and try to come up with an approach that will be suitable in order to prevent a future variant," he said.</p>.<p>The EMA said it was currently in conversation with vaccine developers in case there is a need for an updated vaccine but added that any such change would need to be coordinated globally.</p>.<p><strong>Watch the latest DH videos:</strong></p>
<p id="thickbox_headline">The European Union's drug regulator on Tuesday expressed doubts about the need for a fourth booster dose of Covid-19 vaccine and said there is currently no data to support this approach as it seeks more data on the fast-spreading Omicron variant.</p>.<p>"While use of additional boosters can be part of contingency plans, repeated vaccinations within short intervals would not represent a sustainable long-term strategy," the European Medicines Agency's Head of Vaccines Strategy, Marco Cavaleri, told a media briefing.</p>.<p>The EMA official raised concerns that a strategy of giving boosters every four months hypothetically poses the risk of overloading people's immune systems and leading to fatigue in the population.</p>.<p>Cavaleri also said more data on the impact of the new variant on vaccines and a better understanding of the evolution of the current wave were needed to decide whether an Omicron-specific vaccine was needed.</p>.<p>"It is important that there is a good discussion around the choice of the composition of the vaccine to make sure that we have a strategy that is not just reactive ... and try to come up with an approach that will be suitable in order to prevent a future variant," he said.</p>.<p>The EMA said it was currently in conversation with vaccine developers in case there is a need for an updated vaccine but added that any such change would need to be coordinated globally.</p>.<p><strong>Watch the latest DH videos:</strong></p>